g.ibarra

TL2 · Faro

Contributes reviews on supplier material. Based in Faro.

Joined 12 August 2025 · last posted 8d

88 posts, newest first. Showing up to 150.

Submitting a sample: the process end to end Replied, post #97 · Sourcing › Independent verification · 20 Jul 2026 · 0 likes Post #95 describes the usual case. This is about the unusual one. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #19 · Clinical › Prescriber conversations · 20 Jul 2026 · 29 likes Taking post #16 at face value and following it one step further. Written summaries after an appointment are available in many systems and are worth asking for, because…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #130 · Practice › Reconstitution · 18 Jul 2026 · 1 like Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
Ultrasound and skinfolds: operator dependence in practice Replied, post #60 · Outcomes › Body composition · 16 Jul 2026 · 0 likes Ultrasound and skinfolds: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #43 · Documentation › Doc review · 15 Jul 2026 · 3 likes Reading rather than contributing, but this is the most useful thread I have found on it.
What to bring: records that a clinician can actually use — a second dataset Replied, post #39 · Clinical › Prescriber conversations · 15 Jul 2026 · 2 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
Prescription portability between countries Replied, post #94 · Access › International · 10 Jul 2026 · 7 likes Counterpoint on prescription portability between countries, offered without confidence: the same observation is consistent with a much duller explanation, and nobody…
Fasting versus non-fasting and which tests care Replied, post #66 · Clinical › Bloodwork · 9 Jul 2026 · 1 like Fasting versus non-fasting would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Request: a per-category review queue Replied, post #90 · Meta › Feature requests · 9 Jul 2026 · 18 likes Small request: let me filter Latest by whether I have read the topic. Unread exists as a tab and does not combine with anything else, so a busy category is either all…
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #34 · Compounds › Repair & healing peptides · 27 Jun 2026 · 1 like Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
CJC-1295 with and without DAC: what the modification does Replied, post #95 · Compounds › Secretagogues & GH axis · 27 Jun 2026 · 3 likes Where I part company with post #91, and it is a narrow parting. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #75 · Compounds › Repair & healing peptides · 19 Jun 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Second pass at: Metformin co-administration and additive GI effects Replied, post #119 · Practice › Interactions · 5 Jun 2026 · 23 likes Adding the measurement that post #118 says would settle it. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells…
Reading a home test result without over-claiming Replied, post #56 · Analytics › Home & field testing · 26 May 2026 · 0 likes A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that is the question you had. It is not a purity assay and…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #61 · Practice › Storage & stability · 18 May 2026 · 3 likes Post #58 answers the question as asked. The question underneath it is different. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals…
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #13 · Compounds › Retatrutide · 12 May 2026 · 8 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Reading a trial's population section before its results Replied, post #13 · Evidence › Trials · 11 May 2026 · 0 likes Funding and trial conduct should be stated and are a weak predictor of anything on their own. Design quality is the stronger signal and it is checkable. That is the…
Official shortage notices and what they authorise Replied, post #24 · Access › Shortages · 28 Apr 2026 · 30 likes Post #20 describes the usual case. This is about the unusual one. Supply interruptions: official shortage notices are published by regulatory agencies. That is the…
Designing a personal experiment that could change your mind — one year on Replied, post #35 · Research Methods › N-of-1 designs · 19 Apr 2026 · 3 likes Adding a data point of agreement rather than a data point.
Managing an unplanned gap in supply Replied, post #97 · Access › Shortages · 14 Apr 2026 · 0 likes The question underneath managing an unplanned gap is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
Travelling with an injectable: documentation and practicalities Replied, post #21 · Access › International · 14 Apr 2026 · 3 likes Fair, and the limits you put on it are the part I will remember.
A calculator that gives a right answer to the wrong question Replied, post #15 · Data & Tools › Calculators · 13 Apr 2026 · 1 like The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives. I would not lead a decision…
List price versus negotiated price versus what you pay Replied, post #31 · Access › Pricing · 10 Apr 2026 · 0 likes Where a price includes consultation, device and follow-up, saying so makes a comparison possible. Most quoted figures do not. The literature is thinner on this than the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #90 · Pharmacology › Pharmacokinetics · 1 Apr 2026 · 0 likes Washout came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #24 · Meta › Announcements · 1 Apr 2026 · 21 likes Everything in post #22 holds. The case it does not cover is the one I have. Thank you for announcing it in advance rather than after. The number of places that do the…
Request: export my own posts — one year on Replied, post #63 · Meta › Feature requests · 23 Mar 2026 · 17 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. The evidence…
A parcel stationary at a customs facility for nine days Replied, post #40 · Sourcing › Logistics · 20 Mar 2026 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #118 · Documentation › Wiki requests · 2 Mar 2026 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
Foaming during reconstitution and whether it matters — the long version Replied, post #50 · Practice › Reconstitution · 2 Mar 2026 · 1 like This follows post #49 rather than contradicting it. Two questions I would want answered before drawing anything from the Foaming during reconstitution data above: how…
Measurement error in a self-reported exposure Replied, post #121 · Evidence › Study critique · 27 Feb 2026 · 0 likes Two things can be true about measurement error at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #87 · Clinical › Bloodwork · 27 Feb 2026 · 13 likes Taking post #86 at face value and following it one step further. Worth stating the null on panel before we explain it: the observation may be nothing. That possibility…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #27 · Compounds › Tirzepatide · 26 Feb 2026 · 5 likes Worth stating the null on 2.5 mg starting dose before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Mass error in ppm: the arithmetic and the caveat Replied, post #25 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes Worth separating two things that post #21 runs together. Worth separating mass error in ppm as a question about the compound from mass error in ppm as a question about…
Second pass at: The topic list is dense — is that deliberate? Replied, post #63 · Meta › Site feedback · 5 Feb 2026 · 10 likes Post #61 describes the usual case. This is about the unusual one. One caution on topic list: everything above assumes the underlying documentation is what it claims to…
Designing a personal experiment that could change your mind Replied, post #7 · Research Methods › N-of-1 designs · 30 Jan 2026 · 5 likes Nothing in a personal experiment is medical advice to anyone including yourself, and several people here have found that a prescriber will happily discuss a…
Run-in periods and the population they select Replied, post #50 · Evidence › Trials · 14 Jan 2026 · 1 like Post #49 describes the usual case. This is about the unusual one. Nobody has said the unglamorous part of run-in periods yet, so: most of the variation is explained by…
Aggregates and why a purity assay may miss them entirely Replied, post #67 · Analytics › Impurities & related substances · 12 Jan 2026 · 0 likes A request rather than an answer: could whoever has the primary source for aggregates post it? I have seen the claim three times this month and each version had lost a…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #53 · Practice › Side effects · 8 Jan 2026 · 3 likes Effects that improve with time and effects that improve with dose reduction are different findings. Working out which you have requires holding the dose steady long…
Personal import allowances, compared — a second dataset Replied, post #38 · Access › International · 19 Dec 2025 · 0 likes Answering the question post #36 raises rather than the one it answers. Customs and import outcomes: different routes have different seizure rates. Some countries are…
The decimal-point error, and the habit that catches it Replied, post #75 · Practice › Reconstitution · 17 Dec 2025 · 0 likes Narrowing post #72, because the general version has more than one answer. Decimal-point error: I would want to see the raw numbers rather than the summary before…
Stepping down deliberately, and how to do it without losing progress Replied, post #28 · Practice › Dosing & titration · 16 Dec 2025 · 32 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Realistic expectations for strength while losing weight quickly Replied, post #43 · Nutrition & Training › Resistance training · 10 Dec 2025 · 0 likes Narrowing post #40, because the general version has more than one answer. Adaptation and plateau: if strength does not change for weeks, that is stability, not…
Tirzepatide's shorter half-life and its one practical consequence Replied, post #19 · Compounds › Tirzepatide · 2 Dec 2025 · 15 likes On post #15 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
A parcel that arrived warm: a decision process, not a verdict Replied, post #133 · Practice › Storage & stability · 11 Nov 2025 · 18 likes Where I part company with post #131, and it is a narrow parting. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
[2026 update] What steady state means for the decision to escalate Replied, post #10 · Practice › Dosing & titration · 5 Nov 2025 · 17 likes I changed my mind about steady state after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
EMA product information as a primary source Replied, post #26 · Regional › European Union · 3 Nov 2025 · 6 likes I read post #24 twice before replying, because I had assumed the opposite. The public assessment report published at authorisation is one of the best free technical…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #94 · Compounds › Tirzepatide · 23 Oct 2025 · 28 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
Angle of injection and whether 90 degrees is always right Replied, post #39 · Practice › Administration · 22 Oct 2025 · 22 likes Angle of injection looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
MHRA statements, read directly Replied, post #18 · Regional › UK & Ireland · 19 Oct 2025 · 2 likes Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so themselves.
[2026 update] What a good consultation looks like from the other side Started this topic · Clinical › Prescriber conversations · 13 Oct 2025 · 51 likes The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Good…
Payment method and the leverage it gives you, ranked Started this topic · Sourcing › Payments · 11 Sep 2025 · 56 likes Posting this under the heading it deserves: Payment method and the leverage it gives you, ranked Everything below is what sits behind that. A payments question, with…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #51 · Documentation › Doc review · 3 Sep 2025 · 19 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply. Worth saying I have only my own numbers here, and n is…
Journal club: STEP-HFpEF and symptom endpoints Replied, post #7 · Evidence › Journal club · 2 Sep 2025 · 7 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Written…
Coming back to: Official shortage notices and what they authorise Replied, post #81 · Access › Shortages · 6 Aug 2025 · 10 likes Answering the question post #79 raises rather than the one it answers. The most useful contribution is a link to the current official notice rather than an account of…
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #4 · Clinical › Bloodwork · 6 Aug 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Trying to state the single out-of-range value position in a way that someone who…
A ten-fold dose error caught before injection — one year on Replied, post #100 · Devices › Syringes & needles · 4 Aug 2025 · 24 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
Checking someone else's arithmetic: a worked example thread Replied, post #73 · Practice › Reconstitution · 1 Aug 2025 · 32 likes Post #72 is right about the mechanism and I think understates the practical bit. Worked example, since the arithmetic is the whole question. Five milligrams into one…
How to research a compound with no human data without deceiving yourself Replied, post #13 · Compounds › Other compounds · 30 Jul 2025 · 0 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #18 · Practice › Dosing & titration · 29 Jul 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Started this topic · Practice › Side effects · 21 Jul 2025 · 39 likes Fatigue in the first month: how much is the drug and how much is intake — what changed since Writing it up because I had to work it out twice and would rather nobody…
A field-by-field walk through a certificate of analysis Replied, post #39 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes Answering the question post #36 raises rather than the one it answers. I would rather this thread reach "we do not know" about field-by-field walk through a certificate…
What a documentation review can and cannot tell you Replied, post #35 · Sourcing › Independent verification · 15 Jul 2025 · 6 likes On documentation review I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
Criticising the method without criticising the authors — one year on Replied, post #8 · marked as the solution · Evidence › Study critique · 25 Jun 2025 · 10 likes Post #4 put the caveat in the right place and I want to underline it. Checked the Criticising the method without criticising claim against the primary source this…
Which panel is worth repeating and which is worth ignoring Replied, post #41 · Clinical › Bloodwork · 18 Jun 2025 · 26 likes Answering the question post #37 raises rather than the one it answers. The most useful reply I ever got about panel was a request to state my units. It sounds like…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #125 · Devices › Cold chain · 18 Jun 2025 · 1 like Adding what did not work for me on Domestic fridge temperature mapping, since the failures never get written up and they are half the useful information.
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #9 · Analytics › HPLC & UHPLC · 17 Jun 2025 · 11 likes Narrowing post #7, because the general version has more than one answer. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #5 · marked as the solution · Compounds › Tirzepatide · 15 Jun 2025 · 11 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #13 · Analytics › Method validation · 11 Jun 2025 · 13 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
Validating a calculator against hand arithmetic — what changed since Replied, post #125 · Data & Tools › Calculators · 10 Jun 2025 · 2 likes Post #123 put the caveat in the right place and I want to underline it. A saved calculation is worth more than a remembered one. Write down the inputs alongside the…
High-resolution MS on aggregates and what it can see Replied, post #2 · Analytics › Mass spectrometry · 4 Jun 2025 · 4 likes Two questions I would want answered before drawing anything from the high-resolution data above: how were the cases selected, and what happened to the ones that dropped…
Pre-registering a personal experiment, seriously Replied, post #12 · Research Methods › N-of-1 designs · 26 May 2025 · 25 likes Worth stating the null on pre-registering a personal experiment before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
A claim built entirely on a subgroup analysis Replied, post #15 · Evidence › Study critique · 2 May 2025 · 7 likes Narrowing post #14, because the general version has more than one answer. Two claims get bundled together under claim built and they need separating. The descriptive…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #88 · Sourcing › Red flags · 30 Apr 2025 · 16 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them. Worth saying I have only my own…
Sequence verification for an obscure compound: how it is done Replied, post #22 · Compounds › Other compounds · 28 Apr 2025 · 11 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #27 · Devices › Pens & autoinjectors · 27 Apr 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Reading an MS report that only gives you a single number Replied, post #62 · Analytics › Mass spectrometry · 25 Apr 2025 · 31 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. The…
Cost per milligram, computed honestly across formats — the long version Replied, post #69 · Access › Pricing · 18 Apr 2025 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. Compute cost per delivered dose at your dose if you want a number you can act on. Everything…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #2 · Sourcing › Vendor reports · 14 Mar 2025 · 3 likes The opening post is right about the mechanism and I think understates the practical bit. Reports of ordinary results are more valuable than reports of remarkable ones,…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #74 · Access › International · 2 Mar 2025 · 24 likes Taking post #71 at face value and following it one step further. Where a compound is approved under a different trade name in another market, searching the local name…
Validating a method you did not develop — does this still hold? Replied, post #12 · Analytics › Method validation · 15 Feb 2025 · 0 likes Post #8 put the caveat in the right place and I want to underline it. Robustness testing deliberately varies the parameters most likely to drift — organic percentage,…
Distinguishing a deletion sequence by mass alone Replied, post #76 · Analytics › Mass spectrometry · 11 Feb 2025 · 7 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
Individual participant data versus aggregate data Replied, post #18 · Evidence › Meta-analyses · 10 Feb 2025 · 1 like Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #78 · Sourcing › Regulatory · 4 Feb 2025 · 4 likes Picking up post #75: that is the part I would want checked first. Nothing in this subcategory is legal advice, and the members who work in regulated environments are…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #3 · Compounds › Tirzepatide · 9 Jan 2025 · 6 likes Everything in the opening post holds. The case it does not cover is the one I have. Source for the tirzepatide in type 2 diabetes figure, since it was asked for. It is…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #116 · Compounds › Tirzepatide · 29 Dec 2024 · 23 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #46 · Compounds › Semaglutide · 21 Dec 2024 · 0 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. On the injection-day question: the labelling for licensed semaglutide allows the day…
Washout with a one-week half-life: the arithmetic Replied, post #79 · Research Methods › N-of-1 designs · 6 Dec 2024 · 0 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record.
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #18 · Clinical › Special populations · 15 Nov 2024 · 15 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short. Speaking for…